ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM)

CUSIP: G6333L101

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Stock
Total 13F shares
6,982,600
Share change
+1,008,356
Total reported value
$6,904,000
Price per share
$0.99
Number of holders
18
Value change
+$987,740
Number of buys
11
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP G6333L101?
CUSIP G6333L101 identifies ITRM - ITERUM THERAPEUTICS PLC SHS NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) as of Q4 2020

As of 31 Dec 2020, ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,982,600 shares. The largest 10 holders included Canaan Partners X LLC, FRAZIER MANAGEMENT LLC, New Leaf Venture Partners, L.L.C., Pivotal bioVenture Partners Investment Advisor LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, UBS OCONNOR LLC, Focused Wealth Management, Inc, GRIMES & COMPANY, INC., and CLEAR STREET MARKETS LLC. This page lists 18 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.